American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The development of an in vivo model of checkpoint acquired resistance, reveals a program of interferon hyperstimulation, resulting in dysregulation of MHC class I, protein translation/trafficking, and other unique pathways, that may be useful for guiding clinical strategy in patients with phenotypic similarities
    Meeting Abstract

    Fromm, G. J.; Memon, D.; de Silva, S.; Yoo, K. J.; Johannes, K.; Shuptrine, C.; Miriyala, J.; Patel, A.; Rangwala, F.; Opheim, Z.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Circadian gene expression in metastatic sites and association with survival in metastatic castration-resistant prostate cancer
    Meeting Abstract

    Booker, B. D.; Stopsack, K. H.; Gerke, T. A.; Penny, K.; Kantoff, P. W.; Mucci, L. A.; Markt, S. C.; PCF/SU2C International Prostate Cancer Dream Team
    Cancer Research (2021)

    Fulltext@MSK | Save
  • An SU2C-Mark Foundation Lung collaborative update: Integrative genomics identifies distinct transcriptional states associated with checkpoint blockade resistance
    Meeting Abstract

    Arniella, M. B.; Ravi, A.; Gainor, J.; Stewart, C.; Freeman, S.; Awad, M.; Forde, P.; Anagnostou, V.; Henick, B.; Riess, J. W.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC
    Meeting Abstract

    Ricciuti, B.; Arbour, K. C.; Mahadevan, N. R.; Alessi, J. V.; Lindsay, J.; Umeton, R.; Sinha, R.; Hoojghan, A.; Vokes, N.; Recondo, G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to KRAS G12C inhibition in cancer
    Meeting Abstract

    Awad, M.; Liu, S.; Arbour, K.; Zhu, V.; Johnson, M.; Heist, R.; Patil, T.; Riely, G.; Jacobson, J.; Dilly, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Cholesterol metabolism gene expression and prostate cancer-specific outcomes in radiotherapy-treated patients
    Meeting Abstract

    Winter, S. J.; Halliday, S.; Stopsack, K. H.; Osman, S. O.; Hounsell, A. R.; Prue, G.; Jain, S.; Allott, E. H.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Molecular characteristics of repotrectinib that enable potent inhibition of TRK fusion proteins and broad mutant selectivity
    Meeting Abstract

    Drilon, A.; Zhai, D.; Rogers, E.; Deng, W.; Chen, X.; Sprengeler, P.; Reich, S. H.; Murray, B. W.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Decoding the intimate dialogues between stem cells and immune cell for cancer immunotherapy
    Meeting Abstract

    Truong, C.; Guo, W.; Rudensky, A.; Fuchs, E.; Miao, Y. P.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Tebentafusp induces transient systemic inflammation and modifies the micro-environment to sensitize uveal melanoma tumors to cytotoxic CD8 cells
    Meeting Abstract

    Butler, M. O.; Stanhope, S.; Naidoo, R.; Leach, E.; Kaur, S.; Collins, L.; Abdullah, S.; Ranade, K.; Shoushtari, A. N.
    Cancer Research (2021)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: